(Q38787209)

6 September 2017

title

miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells (English)

1 reference

6 September 2017

1 reference

Koichiro Tsukasa

1

1 reference

6 September 2017

Qiang Ding

2

1 reference

6 September 2017

Yumi Miyazaki

3

1 reference

6 September 2017

Shyuichiro Matsubara

4

1 reference

6 September 2017

Shoji Natsugoe

5

1 reference

6 September 2017

Sonshin Takao

6

1 reference

6 September 2017

publication date

10 March 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

29

1 reference

6 September 2017

issue

3

1 reference

6 September 2017

page(s)

130-137

1 reference

6 September 2017

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Mechanisms of chemoresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial-mesenchymal transition in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Biology and clinical implications of CD133(+) liver cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

MicroRNA function: multiple mechanisms for a tiny RNA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

The evolution of gene regulation by transcription factors and microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Expression of microRNAs in patients with pancreatic cancer and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Down-regulation of miR-30c promotes the invasion of non-small cell lung cancer by targeting MTA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

miR-30b regulates migration and invasion of human colorectal cancer via SIX1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Role of microRNA-30c targeting ADAM19 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

RUNX3 regulates vimentin expression via miR-30a during epithelial-mesenchymal transition in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Retracted: MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-016-0137-7

Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26965588

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

AC133, a novel marker for human hematopoietic stem and progenitor cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26965588

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13577-016-0137-7

1 reference

Dimensions Publication ID

6 September 2017

1026305288

0 references

1 reference